insights_auto
Outlook: 28.2% bullish·23.5% bearish
Go to analysischevron_right
MRNA:NASDAQ
Moderna Inc
၂၁၆.၂၅ US$
arrow_upward
+၁.၁၇%(+၂.၅၁) 1D
၂၁၅.၂၀ US$
arrow_downward
-၀.၄၉% (-၁.၀၅)bedtimeAfter hours
Closed: အောက် ၁၃, GMT-၄ ၁၆:၀၀:၀၁ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MRNA...
Open
၂၀၇.၆၃ US$
High
၂၁၈.၄၈ US$
Low
၂၀၄.၇၀ US$
Mkt. cap
ဋေ ၈.၆၃ ထ
Avg. vol.
၁.၆၆ ကုဋေ
Volume
၁.၃၄ ကုဋေ
52-wk high
၂၂၇.၄၄ US$
52-wk low
၂၂.၂၉ US$
EPS
-၇.၉၈ US$
Beta
၁.၀၉
Shares outstanding
၃၉.၉၂ ကုဋေ
No. of employees
၅ ထောင်
Open
၂၀၇.၆၃ US$
High
၂၁၈.၄၈ US$
Low
၂၀၄.၇၀ US$
Mkt. cap
ဋေ ၈.၆၃ ထ
Avg. vol.
၁.၆၆ ကုဋေ
Volume
၁.၃၄ ကုဋေ
52-wk high
၂၂၇.၄၄ US$
52-wk low
၂၂.၂၉ US$
EPS
-၇.၉၈ US$
Beta
၁.၀၉
Shares outstanding
၃၉.၉၂ ကုဋေ
No. of employees
၅ ထောင်
News stories
From web sources and news partners
ad-hoc-news.de
·
ပြီးခဲ့သည့် ၂၃ မိနစ်
Moderna's November 6 Earnings Date Lands in a Month Full of Signals — Only Some of Them Are Facts
MarketBeat
·
ပြီးခဲ့သည့် ၁ နာရီ
Moderna (NASDAQ:MRNA) Shares Up 1.2% - Here's Why
Benzinga
·
ပြီးခဲ့သည့် ၅ နာရီ
10 Health Care Stocks With Whale Alerts In Today’s Session
The Globe and Mail
·
ပြီးခဲ့သည့် ၅ နာရီ
MRNA Stock Gains Over $4B in a Week: Time to Buy, Hold or Sell?
Profile
Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern".
The company's commercial products are the Moderna COVID-19 vaccine sold under the brand names Spikevax and Mnexspike, a respiratory syncytial virus vaccine sold under the brand name Mresvia, and an influenza vaccine sold under the brand name Mflusiva. The company has 44 treatment and vaccine candidates, of which 37 have entered clinical trials. Candidates include possible vaccines for influenza, HIV, Epstein–Barr virus, the Nipah virus, chikungunya, human metapneumovirus, varicella zoster virus, as well as a cytomegalovirus vaccine, a Zika virus vaccine funded by the Biomedical Advanced Research and Development Authority, and three cancer vaccines.
In May 2026, Time ranked Moderna first in their list of the World's Most Impactful Companies. Wikipedia
About Moderna Inc